Tekla Capital Management LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Tekla Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 13, 2018	SELL	$8.3 - $16.8 $380,588 - $770,347	-45,854 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$8.1 - $16.0 $371,417 - $733,664	45,854 New	45,854 $452,000
Q4 2017 Feb 14, 2018	SELL	$10.5 - $14.15 $325,794 - $439,046	-31,028 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$7.7 - $11.55 $238,915 - $358,373	31,028	31,028 $341,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $496M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.